{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:45:56Z","timestamp":1786697156723,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.acra.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T11:10:15Z","timestamp":1755947415000},"page":"6840-6856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic Value of 18F-FDG PET\/CT Parameters at Baseline and End of Treatment in Follicular Lymphoma: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Xuanxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acra.2025.08.003_bib1","first-page":"443","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.lpm.2019.07.024","article-title":"Follicular lymphoma: an update","volume":"48","author":"Sujobert","year":"2019","journal-title":"Presse Med"},{"key":"10.1016\/j.acra.2025.08.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100992","article-title":"Follicular lymphoma: the long and winding road leading to your cure?","volume":"57","author":"Gordon","year":"2023","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.acra.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tranon.2014.02.010","article-title":"(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application","volume":"7","author":"Li","year":"2014","journal-title":"Transl Oncol"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s12185-022-03418-5","article-title":"High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma","volume":"116","author":"Kuroki","year":"2022","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.acra.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/annonc\/mdq024","article-title":"FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study","volume":"21","author":"Lopci","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acra.2025.08.003_bib8","article-title":"Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET\/CT","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib9","first-page":"202","article-title":"Clinical application of [(18)F]FDG PET\/CT in follicular lymphoma","volume":"41","author":"D\u00edaz-Silv\u00e1n","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.acra.2025.08.003_bib10","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"24","key":"10.1016\/j.acra.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"issue":"22","key":"10.1016\/j.acra.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/sim.1303","article-title":"Aggregate data meta-analysis with time-to-event outcomes","volume":"21","author":"Williamson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.acra.2025.08.003_bib13","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2018-99-117235","article-title":"Baseline PET-derived metabolic tumor volume metrics did not predict outcomes in follicular lymphoma patients treated with first-line immunochemotherapy and antibody maintenance in the phase III GALLIUM study","volume":"132","author":"Barrington","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.annonc.2023.10.121","article-title":"Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial","volume":"35","author":"Cottereau","year":"2024","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.acra.2025.08.003_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/bloodadvances.2017015164","article-title":"Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma","volume":"2","author":"Delfau-Larue","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1038\/s41598-024-58412-0","article-title":"Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG PET in high-burden follicular lymphoma","volume":"14","author":"Draye-Carbonnier","year":"2024","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.acra.2025.08.003_bib17","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/diagnostics13132237","article-title":"Pretreatment CT texture parameters as predictive biomarkers of progression-free survival in follicular lymphoma treated with immunochemotherapy and rituximab maintenance","volume":"13","author":"Durot","year":"2023","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028791","article-title":"Cerebellum\/liver index in pretherapeutic 18F-FDG PET\/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance","volume":"101","author":"Godard","year":"2022","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.acra.2025.08.003_bib19","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s00432-022-04138-3","article-title":"Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden","volume":"149","author":"Leccisotti","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.acra.2025.08.003_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4143\/crt.2018.649","article-title":"Prognostic value of baseline and interim total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT in patients with follicular lymphoma","volume":"51","author":"Liang","year":"2019","journal-title":"Cancer Res Treat"},{"issue":"30","key":"10.1016\/j.acra.2025.08.003_bib21","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2020.263194","article-title":"Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma","volume":"107","author":"Rossi","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.acra.2025.08.003_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1283582","article-title":"Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma","volume":"13","author":"So","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.acra.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s10147-019-01482-2","article-title":"Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma","volume":"24","author":"Tatsumi","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.acra.2025.08.003_bib25","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/CMAR.S216445","article-title":"Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET\/CT in patients with follicular lymphoma","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.acra.2025.08.003_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"issue":"12","key":"10.1016\/j.acra.2025.08.003_bib28","article-title":"Deauville score-based evaluation of interim PET\/CT in follicular lymphoma: a prognostic factor systematic review and meta-analysis","volume":"16","author":"Fonseca","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.acra.2025.08.003_bib29","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00277-023-05274-7","article-title":"Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis","volume":"102","author":"Zheng","year":"2023","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/RCT.0000000000000485","article-title":"Systematic review on the additional value of 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography in staging follicular lymphoma","volume":"41","author":"Adams","year":"2017","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14071","article-title":"18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma","volume":"174","author":"Ujjani","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","article-title":"FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis","volume":"41","author":"Adams","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1016","key":"10.1016\/j.acra.2025.08.003_bib33","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1259\/bjr\/29583493","article-title":"Clinical utility of \u00b9\u2078F FDG-PET\/CT in the detection of bone marrow disease in Hodgkin's lymphoma","volume":"85","author":"Muzahir","year":"2012","journal-title":"Br J Radiol"},{"issue":"11","key":"10.1016\/j.acra.2025.08.003_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood.2020008243","article-title":"Is it time for PET-guided therapy in follicular lymphoma?","volume":"139","author":"Trotman","year":"2022","journal-title":"Blood"},{"issue":"1169","key":"10.1016\/j.acra.2025.08.003_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/bjr\/tqaf028","article-title":"18F-FDG PET or PET\/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis","volume":"98","author":"Lee","year":"2025","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib36","first-page":"312","article-title":"(18)F-FDG PET\/CT in the clinical management of patients with lymphoma","volume":"36","author":"Tamayo","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib37","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-013-2686-2","article-title":"Current role of FDG PET\/CT in lymphoma","volume":"41","author":"Kostakoglu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.08.003_bib38","doi-asserted-by":"crossref","first-page":"21s","DOI":"10.2967\/jnumed.108.057190","article-title":"PET\/CT for therapy response assessment in lymphoma","volume":"50","author":"Hutchings","year":"2009","journal-title":"J Nucl Med"},{"issue":"27","key":"10.1016\/j.acra.2025.08.003_bib39","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.acra.2025.08.003_bib40","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","article-title":"PET\/CT in non-hodgkin lymphoma: an update","volume":"53","author":"Zanoni","year":"2023","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2019.07.001","article-title":"PET\/CT in radiation oncology","volume":"46","author":"Fonti","year":"2019","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.acra.2025.08.003_bib43","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1039\/D3CS00037K","article-title":"Fluorinated carbohydrates for (18)F-positron emission tomography (PET)","volume":"52","author":"Campbell","year":"2023","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.acra.2025.08.003_bib44","first-page":"185","article-title":"Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma","volume":"20","author":"\u00d6m\u00fcr \u00d6","year":"2014","journal-title":"Diagn Interv Radiol"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cpet.2010.05.001","article-title":"(18)F-Fluorodeoxyglucose PET and PET\/CT in pediatric musculoskeletal malignancies","volume":"5","author":"Grant","year":"2010","journal-title":"PET Clin"},{"issue":"4","key":"10.1016\/j.acra.2025.08.003_bib46","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11547-008-0264-7","article-title":"Role of whole-body [18F] fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol Med"},{"issue":"8","key":"10.1016\/j.acra.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","article-title":"The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi","volume":"24","author":"Luminari","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.acra.2025.08.003_bib48","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","article-title":"Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma","volume":"37","author":"Le Dortz","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.acra.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1631\/jzus.B2200644","article-title":"Application of interim PET-CT in first-line treatment decision-making for lymphoma","volume":"24","author":"Huang","year":"2023","journal-title":"J Zhejiang Univ Sci B"},{"issue":"4","key":"10.1016\/j.acra.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3960\/jslrt.23051","article-title":"Highlights: follicular lymphoma","volume":"63","author":"Takata","year":"2023","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"10.1016\/j.acra.2025.08.003_bib51","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/joim.13330","article-title":"Technological readiness and implementation of genomic-driven precision medicine for complex diseases","volume":"290","author":"Franks","year":"2021","journal-title":"J Intern Med"},{"issue":"19","key":"10.1016\/j.acra.2025.08.003_bib52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.acra.2025.08.003_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225007408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225007408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T21:05:41Z","timestamp":1763327141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225007408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1076633225007408"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.08.003","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of 18F-FDG PET\/CT Parameters at Baseline and End of Treatment in Follicular Lymphoma: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}